The use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells

Michal Babic1,2, Daniel Horak1,2, Pavla Jendelova2,3, Vit Herynek2,4, Vladimir Proks1,2, Vaclav Vanecek2,3, Petr Lesny2,3, Eva Sykova2,31Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq 2, 2Center for Cell Therapy and Tissue Repair, Charles University, V...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Babic M, Horak D, Jendelova P, Herynek V, Proks V, Vanecek V, Lesny P, Sykova E
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/f17069b23e224289b691d9a27a6a0c42
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f17069b23e224289b691d9a27a6a0c42
record_format dspace
spelling oai:doaj.org-article:f17069b23e224289b691d9a27a6a0c422021-12-02T00:22:13ZThe use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells1176-91141178-2013https://doaj.org/article/f17069b23e224289b691d9a27a6a0c422012-03-01T00:00:00Zhttp://www.dovepress.com/the-use-of-dopamine-hyaluronate-associate-coated-maghemite-nanoparticl-a9511https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Michal Babic1,2, Daniel Horak1,2, Pavla Jendelova2,3, Vit Herynek2,4, Vladimir Proks1,2, Vaclav Vanecek2,3, Petr Lesny2,3, Eva Sykova2,31Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq 2, 2Center for Cell Therapy and Tissue Repair, Charles University, V Uvalu 84, 3Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 4Institute for Clinical and Experimental Medicine, Videnska 1958, Prague, Czech RepublicAbstract: Sodium hyaluronate (HA) was associated with dopamine (DPA) and introduced as a coating for maghemite (γ-Fe2O3) nanoparticles obtained by the coprecipitation of iron(II) and iron(III) chlorides and oxidation with sodium hypochlorite. The effects of the DPA anchorage of HA on the γ-Fe2O3 surface on the physicochemical properties of the resulting colloids were investigated. Nanoparticles coated at three different DPA-HA/γ-Fe2O3 and DPA/HA ratios were chosen for experiments with rat bone marrow mesenchymal stem cells and human chondrocytes. The nanoparticles were internalized into rat bone marrow mesenchymal stem cells via endocytosis as confirmed by Prussian Blue staining. The efficiency of mesenchymal stem cell labeling was analyzed. From among the investigated samples, efficient cell labeling was achieved by using DPA-HA-γ-Fe2O3 nanoparticles with DPA-HA/γ-Fe2O3 = 0.45 (weight/weight) and DPA/HA = 0.038 (weight/weight) ratios. The particles were used as a contrast agent in magnetic resonance imaging for the labeling and visualization of cells.Keywords: nanoparticles, dopamine, hyaluronate, cell labeling, magneticBabic MHorak DJendelova PHerynek VProks VVanecek VLesny PSykova EDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 1461-1474 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Babic M
Horak D
Jendelova P
Herynek V
Proks V
Vanecek V
Lesny P
Sykova E
The use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells
description Michal Babic1,2, Daniel Horak1,2, Pavla Jendelova2,3, Vit Herynek2,4, Vladimir Proks1,2, Vaclav Vanecek2,3, Petr Lesny2,3, Eva Sykova2,31Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq 2, 2Center for Cell Therapy and Tissue Repair, Charles University, V Uvalu 84, 3Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 4Institute for Clinical and Experimental Medicine, Videnska 1958, Prague, Czech RepublicAbstract: Sodium hyaluronate (HA) was associated with dopamine (DPA) and introduced as a coating for maghemite (γ-Fe2O3) nanoparticles obtained by the coprecipitation of iron(II) and iron(III) chlorides and oxidation with sodium hypochlorite. The effects of the DPA anchorage of HA on the γ-Fe2O3 surface on the physicochemical properties of the resulting colloids were investigated. Nanoparticles coated at three different DPA-HA/γ-Fe2O3 and DPA/HA ratios were chosen for experiments with rat bone marrow mesenchymal stem cells and human chondrocytes. The nanoparticles were internalized into rat bone marrow mesenchymal stem cells via endocytosis as confirmed by Prussian Blue staining. The efficiency of mesenchymal stem cell labeling was analyzed. From among the investigated samples, efficient cell labeling was achieved by using DPA-HA-γ-Fe2O3 nanoparticles with DPA-HA/γ-Fe2O3 = 0.45 (weight/weight) and DPA/HA = 0.038 (weight/weight) ratios. The particles were used as a contrast agent in magnetic resonance imaging for the labeling and visualization of cells.Keywords: nanoparticles, dopamine, hyaluronate, cell labeling, magnetic
format article
author Babic M
Horak D
Jendelova P
Herynek V
Proks V
Vanecek V
Lesny P
Sykova E
author_facet Babic M
Horak D
Jendelova P
Herynek V
Proks V
Vanecek V
Lesny P
Sykova E
author_sort Babic M
title The use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells
title_short The use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells
title_full The use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells
title_fullStr The use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells
title_full_unstemmed The use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells
title_sort use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/f17069b23e224289b691d9a27a6a0c42
work_keys_str_mv AT babicm theuseofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT horakd theuseofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT jendelovap theuseofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT herynekv theuseofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT proksv theuseofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT vanecekv theuseofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT lesnyp theuseofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT sykovae theuseofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT babicm useofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT horakd useofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT jendelovap useofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT herynekv useofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT proksv useofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT vanecekv useofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT lesnyp useofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
AT sykovae useofdopaminehyaluronateassociatecoatedmaghemitenanoparticlestolabelcells
_version_ 1718403839636275200